# Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
Canonical URL: https://biopharmsignal.com/news/IPHA/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results
Ticker: IPHA
Company: Innate Pharma
Source: Innate Pharma
Published: 2026-05-12 13:48 EST
Original Source URL: https://www.innate-pharma.com
## Summary

<span>Innate Pharma présente l'avancée de son portefeuille et ses résultats financiers du premier trimestre 2026</span> <div class="field field--name-field-date-from field--type-datetime field--label-hidden field--item"><i class="fa fa-clock-o" aria-hidden="true"></i> <time datetime="2026-05-13T05:00:00Z">mer, 05/13/20

## Article Body
Innate Pharma présente l'avancée de son portefeuille et ses résultats financiers du premier trimestre 2026

mer, 05/13/2026 - 07:00

Communiqué de Presse en français
                      330.24 Ko
                  
                      
                      Press Release in English
                      254.12 Ko

sch

mar, 05/12/2026 - 17:07
## Recent Company News
- 2026-07-20 14:53 EST — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f) — Source: Innate Pharma
- 2026-05-21 17:08 EST — [Outcome of Innate Pharma’s 2026 Annual General Meeting](https://biopharmsignal.com/news/IPHA/outcome-of-innate-pharma-s-2026-annual-general-meeting) — Source: Innate Pharma
- 2026-05-18 11:27 EST — [Innate Pharma to participate in the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-the-jefferies-global-healthcare-conference) — Source: Innate Pharma
- 2026-05-12 13:48 EST — [Innate Pharma Reports First Quarter 2026 Business Update and Financial Results](https://biopharmsignal.com/news/IPHA/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results) — Source: Innate Pharma
- 2026-05-11 08:09 EST — [Number of shares and voting rights of Innate Pharma as of April 16, 2026](https://biopharmsignal.com/news/IPHA/number-of-shares-and-voting-rights-of-innate-pharma-as-of-april-16-2026) — Source: Innate Pharma
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-na&#239;ve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)